Skip to main content
. 2024 Jun 5;20(1):2351584. doi: 10.1080/21645515.2024.2351584

Figure 1.

Figure 1.

Study design and flow diagram of study participants.

RZV group, participants receiving the adjuvanted recombinant zoster vaccine; placebo group, participants receiving placebo; D, day; M, month; n, number of participants; (S)AE, (serious) adverse event; HZ, herpes zoster.